Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-06-26 | New | $10,999,976 | $10,999,976 | Equity Only | 06b | SEC link |
| 2024-10-17 | New | $6,121,000 | $6,121,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| David Johnson | Director, Executive |
| Alexander Tallett | Director, Executive |